N-Carbamoylhydroxylamine
Brand names,
N-Carbamoylhydroxylamine
Analogs
N-Carbamoylhydroxylamine
Brand Names Mixture
N-Carbamoylhydroxylamine
Chemical_Formula
CH4N2O2
N-Carbamoylhydroxylamine
RX_link
http://www.rxlist.com/cgi/generic2/hydroxyurea.htm
N-Carbamoylhydroxylamine
fda sheet
N-Carbamoylhydroxylamine
msds (material safety sheet)
N-Carbamoylhydroxylamine
Synthesis Reference
No information avaliable
N-Carbamoylhydroxylamine
Molecular Weight
76.0547 g/mol
N-Carbamoylhydroxylamine
Melting Point
142-146 oC
N-Carbamoylhydroxylamine
H2O Solubility
1E+006 mg/L
N-Carbamoylhydroxylamine
State
Solid
N-Carbamoylhydroxylamine
LogP
-1.432
N-Carbamoylhydroxylamine
Dosage Forms
Capsule
N-Carbamoylhydroxylamine
Indication
For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia.
N-Carbamoylhydroxylamine
Pharmacology
Hydroxyurea has dose-dependent synergistic activity with cisplatin in vitro. In vivo Hydroxyurea showed activity in combination with cisplatin against the LX-1 and CALU-6 human lung xenografts, but minimal activity was seen with the NCI-H460 or NCI-H520 xenografts. Hydroxyurea was synergistic with cisplatin in the Lewis lung murine xenograft. Sequential exposure to Hydroxyurea 4 hours before cisplatin produced the greatest interaction.
N-Carbamoylhydroxylamine
Absorption
Well absorbed from the gastrointestinal tract.
N-Carbamoylhydroxylamine
side effects and Toxicity
Oral, mouse: LD50 = 7330 mg/kg; Oral, rat: LD50 = 5760 mg/kg
N-Carbamoylhydroxylamine
Patient Information
HYDREA is a medication that must be handled with care. People who are not taking HYDREA should not be
exposed to it. If the powder from the capsule is spilled, it should be wiped up immediately with a damp disposable
towel and discarded in a closed container, such as a plastic bag. The medication should be kept away from children
and pets.
N-Carbamoylhydroxylamine
Organisms Affected
Humans and other mammals